DPQ hydrochloride

Synonyms: 6,7-Dimethoxy-2-(1-piperazinyl)-4-quinazolinamine hydrochloride
DPQ hydrochloride 是一种具有血脑屏障透过性和选择性的 PARP-1 抑制剂,可通过阻断 PARP-1 介导的 DNA 损伤修复及 NAD+/ATP 消耗来抑制过度炎症反应,同时抑制 NF-κB 通路激活、减少促炎因子(如 TNF-α、IL-6)表达及氧化应激,可用于急性肺损伤、心肌梗死及神经退行性疾病的炎症相关研究。
产品编号: MS-D40154 CAS No.: 84050-22-6 分子式: C14H20ClN5O2 分子量: 325.79
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

DPQ hydrochloride 是一种具有血脑屏障透过性和选择性的 PARP-1 抑制剂,可通过阻断 PARP-1 介导的 DNA 损伤修复及 NAD+/ATP 消耗来抑制过度炎症反应,同时抑制 NF-κB 通路激活、减少促炎因子(如 TNF-α、IL-6)表达及氧化应激,可用于急性肺损伤、心肌梗死及神经退行性疾病的炎症相关研究。

生物实验数据

生物活性 DPQ hydrochloride is a blood-brain barrier-permeable and selective PARP-1 inhibitor that suppresses excessive inflammatory responses by blocking PARP-1-mediated DNA damage repair and NAD+/ATP depletion, while also inhibiting NF-κB pathway activation and reducing the expression of pro-inflammatory factors (such as TNF-α and IL-6) and oxidative stress, and can be used for inflammation-related research in acute lung injury, myocardial infarction, and neurodegenerative diseases.
IC50 & Target

PARP-1

 

体外研究
(In Vitro)

DPQ hydrochloride (10 μM;预处理 30 min,处理 2-8 h) 显著抑制 LPS (100 ng/mL) 刺激的小鼠腹腔巨噬细胞中 TNF-α、IL-1β、IL-6、CXCL-1、MIP-2 和 iNOS 的 mRNA 表达。
DPQ hydrochloride (10 μM;预处理 30 min,处理 2-8 h) 抑制 LPS (100 ng/mL) 诱导的巨噬细胞中 IkB-α 降解及 NF-κB p65 磷酸化,阻断炎症信号通路。

Apoptosis Analysis

Cell Line: Mixed murine cortical neurons
Concentration: 10 μM
Incubation Time: 10 min pretreatment + 20 min NMDA exposure
Result: Reduced NMDA-induced neuronal apoptosis by 84% at 6 h and 50% at 24 h, restored ATP levels from 4% to 72% of control, and suppressed PARP activation.

Real Time qPCR

Cell Line: Murine peritoneal macrophages
Concentration: 10 μM
Incubation Time: 30 min pretreatment + 2-8 h LPS stimulation
Result: Significantly decreased LPS-induced mRNA expression of TNF-α (50% reduction), IL-1β (40%), IL-6 (45%), CXCL-1 (35%), MIP-2 (40%), and iNOS (50%).

Western Blot Analysis

Cell Line: Murine peritoneal macrophages
Concentration: 10 μM
Incubation Time: 30 min pretreatment + 15-60 min LPS stimulation
Result: Blocked LPS-induced IkB-α degradation (50% inhibition at 15 min) and NF-κB p65 phosphorylation (40% reduction at 30 min).

Immunofluorescence

Cell Line: Murine peritoneal macrophages
Concentration: 10 μM
Incubation Time: 30 min pretreatment + 1 h LPS stimulation
Result: Reduced LPS-induced PARP activation (40% decrease in PAR fluorescence intensity) and nitrotyrosine formation (35% reduction).
体内研究
(In Vivo)

DPQ hydrochloride (10 mg/kg;腹腔注射;单次;6 小时) 在 LPS 诱导的 C57BL/6 小鼠急性肺损伤模型中显著减轻肺炎症、中性粒细胞浸润及血管渗漏,抑制 NF-κB 通路激活。
DPQ hydrochloride (10 mg/kg;腹腔注射;单次;4 周) 在 Wistar 大鼠心肌梗死模型中改善心脏功能,减少细胞凋亡及氧化应激损伤。

Animal Model: LPS-Induced Acute Lung Injury Model in C57BL/6 mice (male, 8-10 weeks old)
Dosage: 10 μg/kg (dissolved in 0.01% DMSO (PBS)
Administration: Intraperitoneal injection, 30 min after LPS chanllenge (7.5 mg/kg; ip; single dose)
Result: Reduced neutrophil infiltration (50% decrease), MPO activity (40% decrease), and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in lungs. Restored vascular permeability (Evans blue extravasation reduced by 35%), and inhibited apoptotic cell death (TUNEL-positive cells decreased by 45%).
Suppressed NF-κB activation with reduced IkB-α degradation and p65 phosphorylation.
Animal Model: Wistar rats (male, 4 months old) + MI via coronary artery ligation
Dosage: 10 mg/kg (dissolved in DMSO)
Administration: Intraperitoneal injection, single dose immediately after MI induction
Result: Improved cardiac function (FS increased by 25%, EDD/ESD reduced by 15%), decreased apoptotic cardiomyocytes (TUNEL-positive cells reduced by 40%), and suppressed cleaved caspase-3 and PARP1 expression. Oxidative stress markers (O2-, nitrotyrosine) were reduced by 30-40% in infarcted myocardium.

化学信息

分子量 325.79
分子式 C14H20ClN5O2
CAS No. 84050-22-6
别名 6,7-Dimethoxy-2-(1-piperazinyl)-4-quinazolinamine hydrochloride

储存&溶解度

溶解度信息
DMSO: 50 mg/mL (153.94 mM), Sonication is recommended.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础